当前位置: 首页 > 详情页

Protective effect of 2, 3, 5, 4′-tetrahydroxystilbene-2-β-O-D- glucoside on hippocampal neurons in dementia rats induced by chronic cerebral ischemia

| 导出 |

文献详情

资源类型:

收录情况: ◇ 北大核心

机构: [1]首都医科大学宣武医院药物研究室,教育部神经变性学重点实验室,北京100053 [2]中国药品生物制品检定所,国家药物安全评价监测中心,北京 100176
出处:
ISSN:

关键词: 2 3 5 4′-tetrahydroxystilbene-2-O-β-D-glucoside Antioxidative enzyme Chronic cerebral ischemia Dementia Hippocampal neuron Learning and memory Peroxidation Polygonum multiflorum

摘要:
OBJECTIVE: To detect the changes in learning and memory ability, the injury of hippocampal neurons and the intracephalic peroxidation level in model rats with chronic cerebral ischemia, and to investigate whether 2,3,5,4′- tetrahydroxystilbene-2-O-β-D-glucoside (TSG), the main effective component of polygonum multiflorum, has significant improving and protecting action in the above aspects. METHODS: The chronic cerebral ischemia models were induced by the 8-week permanent ligation of bilateral carotid arteries in male SD rats. Morris water maze and the step-through test were used to detect the learning and memory ability. Nissl's staining was used to show the status of hippocampal neurons. The biochemical methods were used to examine the MDA content and CSH-PX activity in cerebral cortex and hippocampus. RESULTS: In model rats, the spacial learning and memory ability, passive avoidance learning and memory ability were severely impaired, hippocampal neurons and Nissl's bodies were notably reduced, GSH-PX activity significantly decreased, and MDA level increased. The administration of TSG markedly improved the learning and memory ability of model rats, mitigated the injury of hippocampal neurons, increased the GSH-PX activity and decreased the MDA level in both cortex and hippocampus. CONCLUSION: TSG can improve the learning and memory ability of chronic cerebral ischemic model rats, mitigate the injury of hippocampal neurons, increase the antioxidation ability and decrease the peroxidation level in cerebral cortex and hippocampus.

基金:
语种:
第一作者:
第一作者机构: [1]首都医科大学宣武医院药物研究室,教育部神经变性学重点实验室,北京100053 [2]中国药品生物制品检定所,国家药物安全评价监测中心,北京 100176
通讯作者:
通讯机构: [1]首都医科大学宣武医院药物研究室,教育部神经变性学重点实验室,北京100053
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17010 今日访问量:0 总访问量:909 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院